{"entity":{"type":"insider","cik":"0001472130","url":"/insider/0001472130","json_url":"/insider/0001472130.json","name":"Perkins John R II","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2010-09-03","last":"2010-09-03","span_basis":"filed_date"},"name_variants":[{"name":"Perkins John R II","source":"filing","n_filings":2,"first_seen":"2010-09-03","last_seen":"2010-09-03"}],"transactions":[{"id":7368946,"accession":"0001223203-10-000244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223203-10-000244","line_url":"/filing/0001223203-10-000244#line-1","is_derivative":false,"issuer_cik":"0001405197","issuer_name":"Talecris Biotherapeutics Holdings Corp.","issuer_ticker":"V9SNSIJ","issuer_name_source":null,"issuer_url":"/issuer/0001405197","owner_cik":"0001472130","owner_name":"Perkins John R II","owner_url":"/insider/0001472130","role":"Officer (EVP, Global Commercial)","officer_title":"EVP, Global Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":237937.0,"shares_display":"237,937","price_per_share":22.304,"price_display":"22.30","price_state":"stated","total_value":5306946.848,"total_display":"5,306,946.85","shares_owned_after":22881.0,"shares_owned_after_display":"22,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-02","filed_date":"2010-09-03","scope":"insider"},{"id":7551950,"accession":"0001225208-10-020369","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-020369","line_url":"/filing/0001225208-10-020369#line-2","is_derivative":false,"issuer_cik":"0001405197","issuer_name":"Talecris Biotherapeutics Holdings Corp.","issuer_ticker":"TLCR","issuer_name_source":null,"issuer_url":"/issuer/0001405197","owner_cik":"0001472130","owner_name":"Perkins John R II","owner_url":"/insider/0001472130","role":"Officer (Sr.VP & GM, Portfolio & US Bus)","officer_title":"Sr.VP & GM, Portfolio & US Bus","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10200.0,"shares_display":"10,200","price_per_share":22.3,"price_display":"22.30","price_state":"stated","total_value":227460.0,"total_display":"227,460.00","shares_owned_after":47494.0,"shares_owned_after_display":"47,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-01","filed_date":"2010-09-03","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001405197","name":"Talecris Biotherapeutics Holdings Corp.","url":"/issuer/0001405197","role":"Officer (EVP, Global Commercial)","n_filings":2,"first_seen":"2010-09-03","last_seen":"2010-09-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001472130","retrieved_at":"2026-08-21T00:33:50+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}